描述

Mechanisms through which gut microbiota modulation may influence non-alcoholic fatty liver disease (NAFLD) progression. The gut-liver axis and microbial metabolite trafficking are central to the proposed therapeutic framework.

Figure 6

Diagram

Source Paper

Gut Microbiota-Targeted Therapeutics for Metabolic Disorders: Mechanistic Insights into the Synergy of Probiotic-Fermented Herbal Bioactives.

International journal of molecular sciences (2025)

PMID: 40564947

DOI: 10.3390/ijms26125486

Cite This Figure

![Figure 6: Mechanisms through which gut microbiota modulation may influence non-alcoholic fatty liver disease (NAFLD) progression. The gut-liver axis and microbial metabolite trafficking are central to the proposed therapeutic framework.]()

> Source: Yue Fan et al. "Gut Microbiota-Targeted Therapeutics for Metabolic Disorders: Mechanistic Insigh." *International journal of molecular sciences*, 2025. PMID: [40564947](https://pubmed.ncbi.nlm.nih.gov/40564947/)

<figure>
  <img src="" alt="Mechanisms through which gut microbiota modulation may influence non-alcoholic fatty liver disease (NAFLD) progression. The gut-liver axis and microbial metabolite trafficking are central to the proposed therapeutic framework." />
  <figcaption>Figure 6. Mechanisms through which gut microbiota modulation may influence non-alcoholic fatty liver disease (NAFLD) progression. The gut-liver axis and microbial metabolite trafficking are central to the proposed therapeutic framework.<br>  Source: Yue Fan et al. "Gut Microbiota-Targeted Therapeutics for Metabolic Disorders: Mechanistic Insigh." <em>International journal of molecular sciences</em>, 2025. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40564947/">40564947</a></figcaption>
</figure>

描述

Figure 6

Source Paper

Cite This Figure

相关证据